-The Telegraph ‘Ill-timed, improper’ amendment notified by Centre a bid by ruling party to take ‘undue advantage’, says former economic affairs secretary New Delhi: Former Union economic affairs secretary E.A.S. Sarma has asked the Election Commission of India to prevent the fresh sale of electoral bonds, as allowed under an amendment notified by the Centre on Monday that he described as “ill-timed, improper” and as a bid by the ruling party to...

-The Hindu It justifies the ‘intelligible differentia’ between Scheduled Castes practising Hinduism, Sikhism, and Buddhism and those practising other religions The affidavit filed by the Union government before the Supreme Court Bench hearing the case for the inclusion of Dalit Christians and Dalit Muslims on the list of Scheduled Castes contradicts itself at several junctures, leading to a lack of clarity on its arguments defending the current criteria for determining which communities...

-The Hindu The scientists in the institute have identified a few locations in the higher reaches of Uttarakhand for “densification” of seismometers and river gauges to take the total number to 100 from 60. The National Geophysical Research Institute (NGRI) of the Council of Scientific and Industrial Research has begun field studies to put in place an early-warning system in the Himalayan States against major and sudden floods, rockslides, landslips, glacier lake...

-Newsclick.in None of its stated objectives have been met and the entire exercise has turned out to be a mere act of converting old notes into new ones, at great inconvenience to the people. In the entire history of post-Independence India, no single economic measure has been as devastating for the people and as utterly futile in achieving its stated objectives, as the demonetisation of currency notes of Rs 500 and Rs...

-TheWire.in The US drug regulator says Lupin Limited's response to tackling genotoxic impurities was not adequate. New Delhi: The US Food and Drug Administration (FDA) has sent a warning letter to the Indian pharmaceutical company Lupin Limited after deeming its efforts to address violations of various good manufacturing practices at its facility in Tarapur, Maharashtra “inadequate”. The FDA sends a ‘warning letter’ to a manufacturer if it has “significantly violated” the agency’s regulations....